Navigation Links
Mettler-Toledo International Inc. Reports Second Quarter 2013 Results
Date:7/25/2013

COLUMBUS, Ohio, July 25, 2013 /PRNewswire/ -- Mettler-Toledo International Inc. (NYSE: MTD) today announced second quarter results for 2013.  Provided below are the highlights:

  • Sales in local currency increased by 1% in the quarter compared with the prior year.  Reported sales also increased 1%, as currency did not impact sales growth in the quarter.
  • Net earnings per diluted share as reported (EPS) were $2.24, compared with $1.93 in the second quarter of 2012.  Adjusted EPS was $2.35, an increase of 9% over the prior-year amount of $2.15.  Adjusted EPS is a non-GAAP measure and excludes purchased intangible amortization, discrete tax items, restructuring charges and other one-time items.  A reconciliation to EPS is provided on the last page of the attached schedules. 
  • Second Quarter ResultsOlivier Filliol, President and Chief Executive Officer, stated, "Market conditions remain challenging, particularly in China.  However, with the continued strong execution in our various margin improvement and cost control initiatives, we generated good growth in EPS." 

    EPS in the second quarter was $2.24, compared with the prior-year amount of $1.93.  Adjusted EPS was $2.35, an increase of 9% over the prior-year amount of $2.15.Sales were $578.7 million, a 1% increase in local currency sales, compared with $570.3 million in the prior-year quarter.  Reported sales also increased 1%, as currency did not impact sales growth in the quarter.  By region, local currency sales increased 5% in the Americas, 2% in Europe and decreased 5% in Asia / Rest of World.  Adjusted operating income amounted to $106.4 million, a 5% increase from the prior-year amount of $101.1 million.  Adjusted operating income is a non-GAAP measure, and a reconciliation to earnings before taxes is provided in the attached sched
    '/>"/>

    SOURCE Mettler-Toledo International Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
    2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
    3. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
    4. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
    5. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
    6. Chindex International, Inc. to Report First Quarter 2012 Financial Results
    7. VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
    8. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
    9. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
    10. Bacterin International Signs Its Third National GPO Contract with Novation
    11. SurgLine International, Inc. Chief Executive Officer, Thomas Toland, Exclusive Interview on Stock Traders Talk Radio
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/21/2014)... 21, 2014  Heated dialogue in recent months about ... cancer treatments to Gilead,s new hepatitis C drug Harvoni® ... world questioning what it means to put a price ... And while drug pricing is one of the ... both a general business and ethical standpoint – it ...
    (Date:11/21/2014)... , Nov. 21, 2014 ... the European Medicines Agency (EMA) has granted ... company,s lead product candidate, for the treatment ... a rare, severely disabling genetic disease characterized ... swelling (flare-ups) and new abnormal bone formation. ...
    (Date:11/21/2014)... , Nov. 20, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: ... , Chief Executive Officer, will be presenting at the 26 ... York Palace Hotel in New York . ... at 2:00 PM ET. In addition, Mr. Krakauer and ... for separate one-on-one meetings during the day. ...
    Breaking Medicine Technology:"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 3"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 4"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 5Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3
    ... IRIDEX Corporation (NASDAQ: IRIX ) today announced that it ... after the market closes on Thursday, March 1, 2012. ... a conference call with the investment community at 5:00 ... 2012 to discuss the results of the quarter and ...
    ... Medical Corp.,s (Nasdaq Market: ESMC) subsidiary,  Sonomed Escalon™ announced ... AXIS™ Image Management System at the recent World Ophthalmology ... Matthew Carnevale, Chief Technical Officer, stated that ... ophthalmic diagnostic imaging management, and provides an entirely new ...
    Cached Medicine Technology:Sonomed Escalon™ Announces Release of AXIS™ iPad App 2Sonomed Escalon™ Announces Release of AXIS™ iPad App 3
    (Date:11/22/2014)... is an important company in the dress industry. The ... online market share by a series of promotions. Recently, it ... a bridesmaid dress promotion for the new year 2015. The ... dresses from this company are not only of high quality ... good at manufacturing wedding dresses. Customers prefer to choose the ...
    (Date:11/22/2014)... to provide better services, LunaDress has updated its website with ... that a suitable cocktail party dress is crucial for every ... dresses supplier’s high quality items are offered at attracting prices, ... industry, LunaDress understands that it is not easy to provide ... the professional level and innovation ability. The growth of sales ...
    (Date:11/22/2014)... Dallas, TX (PRWEB) November 22, 2014 ... Society (ICS) as the complaint that the individual ... times for voiding. The report “Nocturia – Pipeline ... therapeutic development for Nocturia, complete with comparative analysis ... mechanism of action (MoA), route of administration (RoA) ...
    (Date:11/22/2014)... "My friend went in for a mammogram and ... an inventor from Cambria Heights, N.Y. "To add insult ... time because the first results were inaccurate. Her misfortune ... MAMO EASY to offer a more comfortable way to ... from the pain normally involved with this procedure. The ...
    (Date:11/22/2014)... November 22, 2014 A petition seeking ... http://www.morcellatorlawsuit2015.com ) in minimally-invasive hysterectomies and fibroid removal ... the end of October, Bernstein Liebhard LLP reports. ... as of November 21st, 2014. That represents an increase ... had signed on to the campaign.* , The campaign ...
    Breaking Medicine News(10 mins):Health News:Bridesmaid Dresses Introduced by Famous Company Discount-Dress.com For The New Year 2015 2Health News:LunaDress Unveils Fabulous Cocktail Party Dresses 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 3Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 4Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 4
    ... (HealthDay News) -- Children who are allergic to penicillin ... additional drug allergies, new research suggests. Pediatric patients ... authors noted. Prior research in adults has suggested that ... allergies to other medications. But in the new ...
    ... one Michigan State University professor will explore why in old ... whites. Prior research also shows of those 71 years ... mild cognitive impairment, or various types of mental processing problems, ... first to produce statistics about life expectancy with and without ...
    ... new study conducted by Boston University School of Medicine (BUSM) ... believe that chewing the plant khat is harmful to one,s ... The study, which is published online in the journal ... 2013 students Paul Yi, John Kim and Khalil Hussein. Richard ...
    ... warned that, in addition to causing obesity, eating too ... risk for colon cancer. Now, researchers at Temple University ... The findings, "Epigenetic Differences in Normal Colon Mucosa of ... in the March issue of the American Association for ...
    ... HIV-positive patient, one of her first questions is whether he ... response is about dead relatives or friends. "We talk about ... experience will be very different," said the infectious-disease specialist at ... "Yes it,s the same virus and could have the same ...
    ... - Researchers from Boston University School of Medicine (BUSM) ... with breast pain who receive imaging (mammograms, MRIs or ... diagnostic testing, but do not gain benefit from these ... Journal of General Internal Medicine. Breast pain ...
    Cached Medicine News:Health News:Kids' Penicillin Allergy May Not Signal Other Drug Reactions 2Health News:New research will shed light on racial gap in dementia 2Health News:BUSM student-published study focuses on khat chewing in Yemeni culture 2Health News:Study shows how high-fat diets increase colon cancer risk 2Health News:Federal grant enables HIV testing, treatment in the Augusta area 2Health News:Federal grant enables HIV testing, treatment in the Augusta area 3Health News:Research finds little benefit of breast imaging tests for women with breast pain 2
    For the quantitative determination of Inorganic Phosphorus in serum. Linearity: 12.0 mg/dl....
    Amylase (EPS-G7, kinetics), Wavelength: 405 nm. Linear range; 5-1500 IU/L....
    For the kinetic quantitative determination of g-Glutamyl Transferase in serum for manual and/or automated procedures....
    Intended for the quantitative determination of alphaamylase activity in serum. Single vial, dry powder reagent. Reaction: Kinetic. Wavelength: 405 nm. Linearity: 2000 U/L at 37C....
    Medicine Products: